Paxlovid

Paxlovid, the on-patent, antiviral drug Pfizer fast-tracked for COVID-19 early treatment after a year of insisting there was no reliable early treatment for COVID-19, has been getting some marketing attention recently.

A retired surgeon contracted COVID, but was prepared with his "Just-in-Case kit." He also tested ivermectin and Paxlovid on himself.

On The HighWire with Del Bigtree, Dr. Pierre Kory didn’t hold back when speaking about the brand $panking new “anti-viral” Paxlovid.

Paxlovid: A Guide to Making an Informed Decision - This Q&A from the Canadian COVID Care Alliance answers a number of targeted questions to better understand the oral antiviral medication currently being offered for COVID treatment.

Post-Vaccine Syndrome, Hepatitis and Q&A -- The doctors talked about post-vaccine syndrome, including the typical symptoms and how it differs from long COVID.

For this week’s webinar, we opened the floor up to the audience for Q&A on Paxlovid, ivermectin and a lot more

By mentioning a Pfizer drug by name in his State of the Union Address, Biden showed the clear bias this government has for expensive, high-profit drugs while ignoring lower-cost treatments.

Trials of generic medicines that are funded and influenced by profit-driven pharmaceutical companies will always fail.